Trials / Recruiting
RecruitingNCT07010900
Platelet-Rich Plasma Injections From Cord Blood + Penile Traction vs. Penile Traction Alone in Patients With Peyronie's Disease. Open-label, Single-center Randomized Study
Platelet-Rich Plasma Injections From Cord Blood + Penile Traction vs. Penile Traction Alone in Patients With Peyronie's Disease.
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 42 (estimated)
- Sponsor
- Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · Academic / Other
- Sex
- Male
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this clinical trial is to learn if Platelet-Rich Plasma Injections from Cord Blood (CB-PRP) is useful in Peyronie disease. The primary goal is evaluation of patient satisfaction at 1 and 3 months after treatment completion using the PDQ Questionnaire Secondary Objectives are: * Measurement of penile curvature measured with a goniometer with spontaneous erection before and after treatment (1 and 3 months) * Measurement of penile length in stretching before and after treatment (1 and 3 months) * Evaluation of the improvement in quality of life, through the Short-Form Health Survey 12 (SF-12) health status questionnaire and through the Hospital Anxiety and Depression Scale (HADS) Participants will be randomized in two groups: * penile extender alone * penile extender + CB PRP injection (1 injection every 15 days - 3 in totalinjections)
Conditions
- Peyronie Disease
- Penile Curvature
- PRP Injection
- Cord Blood
- Randomised Clinical Trial
- Penile Injection Therapy
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Injection | patients randomized in intervention group will use also penile extender |
Timeline
- Start date
- 2025-05-28
- Primary completion
- 2026-12-31
- Completion
- 2026-12-31
- First posted
- 2025-06-08
- Last updated
- 2025-06-08
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT07010900. Inclusion in this directory is not an endorsement.